List of AM cannabinoids

• AM-087 — an analgesic CB₁ agonist derived from Δ⁸THC substituted with a side chain on the 3-position, it has a K_i of 0.43nM making it roughly 100x as potent as THC.
• AM-251 — an inverse agonist at the CB₁ cannabinoid receptor that is structurally related to SR141716A, but has a higher binding affinity with a K_i value of 7.5nM.
• AM-279 — a Schedule I substance in Alabama.
• AM-281 — N--1--5--4-methyl-1H-pyrazole-3-carboxamide
• AM-356 — a synthetically created stable chiral analog of anandamide, it acts on the cannabinoid receptors with a K_i of 17.9nM at CB₁ and 868nM at CB₂.
• AM-374 — palmitylsulfonyl fluoride
• AM-381 — stearylsulfonyl fluoride
• AM-404 — an active metabolite of paracetamol and a likely inhibitor of fatty acid amide hydrolase
• AM-411 — an adamantyl-substituted derivative of Δ⁸THC, it is a potent and fairly selective CB₁ full agonist with a K_i of 6.80nM. It is also a moderately potent CB₂ agonist with a K_i of 52.0nM.
• AM-630 — a potent and selective inverse agonist for the cannabinoid receptor CB₂, with a K_i of 32.1nM at CB₂ and 165x selectivity over CB₁, at which it acts as a weak partial agonist.
• AM-661 — 1-methyl-2-methyl-3-benzoylindole
• AM-678 — another name for JWH-018, it is a full agonist at both cannabinoid receptors with some selectivity for CB₂.
• AM-679 — an iodobenzoylindole which acts as a moderately potent agonist for the cannabinoid receptors, with a K_i of 13.5nM at CB₁ and 49.5nM at CB₂.
• AM-694 — an iodobenzoylindole which acts as a potent and selective agonist for the CB₁ cannabinoid receptor, with a K_i of 0.08nM at CB₁ and 18x selectivity over the related CB₂ receptor.
• AM-735 — 3-bornyl-Δ8-THC, a mixed CB₁ / CB₂ agonist with K_i of 8.9nM at CB₁ and 7.4nM at CB₂.
• AM-855 — an analgesic derivative of Δ⁸tetrahydrocannabinol, it is an agonist at both CB₁ and CB₂ with moderate selectivity for CB₁, with a K_i of 22.3nM at CB₁ and 58.6nM at CB₂.
• AM-881 — a chlorine-substituted stereoisomer of anandamide whose K_i = 5.3nM at CB₁ and 95nM at CB₂.
• AM-883 — an allyl-substituted stereoisomer of anandamide whose K_i = 9.9nM at CB₁ and 226nM at CB₂.
• AM-905 — a potent and reasonably selective agonist for the CB₁ cannabinoid receptor, with a K_i of 1.2nM at CB₁ and 5.3nM at CB₂.
• AM-906 — a potent and dodecally selective agonist for the CB₁ cannabinoid receptor, with a K_i of 0.8nM at CB₁ and 9.5nM at CB₂.
• AM-919 — a potent agonist at both CB₁ and CB₂ with moderate selectivity for CB₁, with a K_i of 2.2nM at CB₁ and 3.4nM at CB₂. It is a derivative of HU-210 and represents a hybrid structure between the classical and nonclassical cannabinoid families.
• AM-926 — a potent agonist at both CB₁ and CB₂ with moderate selectivity for CB₁, with a K_i of 2.2nM at CB₁ and 4.3nM at CB₂. It is a derivative of HU-210 and represents a hybrid structure between the classical and nonclassical cannabinoid families.
• AM-938 — a potent agonist at both CB₁ and CB₂ with quadruple selectivity for CB₂, with a K_i of 1.2nM at CB₁ and 0.3nM at CB₂. It is a derivative of HU-210 and represents a hybrid structure between the classical and nonclassical cannabinoid families.
• AM-1116 — a dimethylated stereoisomer of anandamide whose K_i = 7.4nM at CB₁.
• AM-1172 — an endocannabinoid analog specifically designed to be a potent and selective inhibitor of AEA uptake that is resistant to FAAH hydrolysis.
• AM-1220 — a potent and selective analgesic CB₁ agonist with a K_i of 3.88nM at CB₁ and 73.4nM at CB₂, giving it 19x selectivity for CB₁. enantiomer has around 1000x higher affinity for CB₁ than enantiomer.
• AM-1221 — a potent and selective CB₂ agonist with a K_i of 0.28nM at CB₂ and 52.3nM at CB₁, giving it a selectivity of almost 187x.
• AM-1235 — a moderately CB₁ selective agonist, with a K_i of 1.5nM at CB₁ and 20.4nM at CB₂, giving it a selectivity of around 13x.
• AM-1241 — a potent and selective analgesic CB₂ agonist with a K_i of 3.4nM at CB₂ and 80x selectivity over CB₁.
• AM-1248 — a moderately potent agonist with some selectivity for CB₁, containing an unusual 3- substitution on the indole ring.
• AM-1710 — a CB₂ selective cannabilactone with 54x selectivity over CB₁. Acts as a dual CB₂ agonist / CB₁ antagonist.
• AM-1714 — a CB₂ selective cannabilactone with 490x selectivity over CB₁.
• AM-1902 — a nonclassical cannabinoid
• AM-2201 — a potent agonist at both CB₁ and CB₂ with moderate selectivity for CB₁, with a K_i of 1.0nM at CB₁ and 2.6nM at CB₂.
• AM-2212 — a potent agonist at both CB₁ and CB₂ with dodecal selectivity for CB₁, with a K_i of 1.4nM at CB₁ and 18.9nM at CB₂.
• AM-2213 — a potent agonist at both CB₁ and CB₂ with 10x selectivity for CB₁, with a K_i of 3.0M at CB₁ and 30nM at CB₂.
• AM-2232 — a potent agonist at both CB₁ and CB₂, with a K_i of 0.28nM at CB₁ and 1.48nM at CB₂.
• AM-2233 — enantiomer is potent and selective CB₁ agonist used in ¹³¹I radiolabelled form to map distribution of CB₁ receptors in brain.
• AM-2389 — classical cannabinoid derivative with 26x selectivity for CB₁.
• AM-3102 — an analog of oleoylethanolamide, the endogenous agonist for proliferator-activated receptor α. It also acts as a weak cannabinoid agonist with K_i values of 33μM at CB₁ and 26μM at CB₂.
• AM-4030 — a potent agonist at both CB₁ and CB₂, it is dodecally selective for CB₁, with a K_i of 0.7nM at CB₁ and 8.6nM at CB₂. It is a derivative of HU-210 and represents a hybrid structure between the classical and nonclassical cannabinoid families.
• AM-4054 — a potent but slow-onset agonist with CB₁ affinity of 2.2nM and a 40x selectivity for CB₁ over CB₂.
• AM-4056 — Another name for HU-243, it is a potent agonist at both the CB₁ and CB₂ receptors, with a binding affinity of 0.041 nM at the CB₁ receptor.
• AM-4113 — a CB₁ selective neutral antagonist.
• AM-6545 — a peripherally selective silent antagonist of CB₁ receptors.